US 12,440,437 B2
Hydrophobic oral care compositions with hydrophobic herbal extract
Puneet Nanda, Beverly Hills, CA (US)
Assigned to GURUNANDA, LLC, Buena Park, CA (US)
Filed by GURUNANDA, LLC, Buena Park, CA (US)
Filed on Sep. 10, 2024, as Appl. No. 18/830,292.
Application 18/830,292 is a continuation of application No. 18/585,677, filed on Feb. 23, 2024.
Claims priority of provisional application 63/625,271, filed on Jan. 25, 2024.
Prior Publication US 2025/0241846 A1, Jul. 31, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 8/9789 (2017.01); A61K 8/37 (2006.01); A61K 8/67 (2006.01); A61K 8/9794 (2017.01)
CPC A61K 8/9789 (2017.08) [A61K 8/37 (2013.01); A61K 8/67 (2013.01); A61K 8/678 (2013.01); A61K 8/9794 (2017.08); A61K 2236/37 (2013.01); A61K 2800/30 (2013.01)] 15 Claims
 
1. A hydrophobic oral formulation, comprising:
(i) a mixture of triglycerides having 8 carbon atoms or 10 carbon atoms present in an amount of at least 96% by weight of the formulation,
wherein the triglyceride mixture comprises about 40% to about 60% triglycerides having 8 carbon atoms,
wherein the mixture of medium chain triglycerides is substantially free of fatty acids having 12 carbon atoms or greater;
(ii) one or more oil soluble plant extracts present in an amount ranging from 0.001% to 5% by weight of the formulation selected from ashwagandha extract, neem extract, turmeric extract, and combinations thereof;
(iii) one or more plant-derived anti-microbial oils present in an amount ranging from 0.04% to 15% by weight of the formulation selected from oregano oil, tea tree oil, clove oil, cinnamon bark oil, and combinations thereof; and
(iv) one or more vitamins present in an amount ranging from 0.0001% to 5% by weight of the formulation selected from vitamin E, vitamin A, beta carotene, vitamin D2, vitamin D3, vitamin D4, vitamin D5, vitamin K1, vitamin K2, and combinations thereof,
wherein each of the ingredients of (ii), (iii), and (iv) are soluble in the mixture of triglycerides of (i), improving penetration of the formulation through oral biofilm and enhancing delivery of the ingredients of (ii), (iii), and (iv).